Infertility Treatment Market Analysis and Forecast to 2031: By Product (Equipment, Media & Consumables, Accessories), Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Other), Patient Type (Female, Male), End User
Description
Infertility Treatment Market Analysis and Forecast to 2031: By Product (Equipment, Media & Consumables, Accessories), Procedure (Assisted Reproductive Technology, Artificial Insemination, Fertility Surgeries, Other), Patient Type (Female, Male), End User (Fertility Centers, Hospitals & Surgical Clinics, Cryobanks, Research Institutes), and Region
The global infertility treatment market was valued at USD 1.6 billion in 2021 and it is anticipated to grow further up to USD 3.6 billion by 2031, at a CAGR of 8.4% during the forecast period.
The inability of a person to reproduce naturally is known as infertility. There are several causes of infertility. The few causes include the aging of the mother, ovulatory problems, tubal obstruction or blockage, sex-transmitted diseases, immunological infertility, genetics, and infertility brought on by male factors. One way to treat infertility is to raise awareness. Other alternatives include IVF (in vitro fertilization), insemination, and drugs that help the body develop during the ovulation phase. The fertility procedure in which the body processes the sperm and eggs out of the body is referred to as assisted reproductive technology (ART). In an ART operation, a woman's ovaries are surgically removed, her eggs are fused with sperm in a lab, and either she returns the eggs to her body or donates them to another woman. With the aid of many diagnostic techniques, including ultrasound, physical examination, and evaluating sperm count & quality, among others, infertility can be identified in both men and women.
Market Trends and Drivers
Due to a variety of circumstances, including the rising trend of late marriages and the rise in age-related infertility, the fertility rate globally is progressively dropping. By 2030, it is predicted that there will be 2.4 offspring for every woman worldwide, and by 2050, there will be 2.2. The need for infertility treatment items that identify the reproductive window in males and females has significantly increased as a result of the dropping fertility rate.
Similarly, players in the infertility treatment market can expect to find considerable growth possibilities in emerging markets like China, India, Brazil, and Mexico. The increased emphasis on healthcare infrastructure upgrades is what distinguishes the market for infertility treatments in Asia and other emerging nations. The medical tourism sector is also flourishing in developing nations for a variety of reasons. Numerous doctors and surgeons throughout Asia have received their training at prestigious institutions in the US and Europe, and healthcare facilities and procedures are of a high standard. Emerging nations like India, China, Singapore, Thailand, Brazil, and Malaysia offer a lot of potential for the expansion of the market for infertility treatments. Players are increasingly focusing on strategic agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions to increase their presence in these markets and tap a large number of customers in order to take advantage of the significant growth opportunities in emerging countries. Additionally, government measures to make infertility treatments more accessible as well as the rise in fertility clinics are causing an increase in infertility treatment procedures in developing nations.
Market Restraints and Challenges
Thousands of rounds of ART procedures including in vitro fertilization (IVF) are carried out year across the globe in addition to reproductive surgery. Due to the absence of reimbursement policies, the cost of IVF therapy varies from nation to nation. The development of this market is being constrained by a lack of insurance coverage and a problematic reimbursement environment in several regions of the world.
Global Infertility Treatment Market Segmental Overview
The report analyses the global infertility treatment market based on the product, procedure, patient type, end user, and region.
Global Infertility Treatment Market by Product
Based on the product, it is segmented into equipment, media & consumables, and accessories. The equipment segment is anticipated to capture the largest share in infertility treatment market. The existence of well-established firms with a robust product lineup and technological developments are to thank for this industry's rapid rise. Along with the players' increasing attention to base development through the use of various tactics, such as the introduction of new equipment, showcases throughout the world are likely to aid in the segment's growth.
Global Infertility Treatment Market by Procedure
Based on the procedure, it is segmented into assisted reproductive technology, artificial insemination, fertility surgeries, and others. The assisted reproductive technology segment is anticipated to dominate the market during the forecast period. The segment's expansion is projected to be aided by the increasing popularity of ART, its rising success rate, and its expanding acceptance on a global scale.
Global Infertility Treatment Market by Patient Type
Based on the patient type, it is segmented into females and males. The female infertility treatment segment is anticipated to dominate the market during the forecast period. The market for treating female infertility is expanding as a result of declining female fertility rates, increased availability of different fertility treatment choices, and an increase in the number of reproductive clinics around the world.
Global Infertility Treatment Market by End User
Based on the end user, it is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment accounted for the largest share of the infertility treatment market during the forecast period. Some of the factors that are likely to contribute to the segment's rapid growth include the rising government initiatives to establish fertility clinics, initiatives taken by major international healthcare providers to establish fertility centers, and the rising popularity of IVF and ICSI treatment globally.
Geographical Analysis of the Global Infertility Treatment Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is anticipated to dominate the market during the forecast period. Significant increase in medical travel, increasing public knowledge of the availability of infertility treatment options, expansion of fertility clinics in the region, rising healthcare costs, rising infertility rates in the region, and government measures to make infertility treatment more accessible in developing countries.
Major Players in the Global Infertility Treatment Market COVID-19 Impact
Currently, the coronavirus pandemic is posing a number of difficulties for patients and clinical healthcare professionals all around the world. The main hurdles facing healthcare systems around the world are logistical problems, managing patients with the disease, prioritizing patients with comorbidities and pre-existing disorders, and protecting public and hospital frontline employees from contact with the COVID-19 virus. Infertility affects one in six couples of reproductive age, and many of them seek out therapies like intrauterine insemination (IUI) and in vitro fertilization (IVF), which call for in-person consultations to be completed. Only 5 lakhs of the 30 lakh persons who seek infertility treatment in India each year actually have IVF or intrauterine insemination (IUI) procedures done. During the COVID-19 epidemic, there was a 90% decrease in the number of IVF cycles performed. The spread of COVID-19 has had an impact on couples that were considering IVF treatment prior to the pandemic as well as fertility clinics due to the cancellation of IVF procedures.
Recent Developments
Q1. How big is the Infertility Treatment market?Ans. The global Infertility Treatment market size was USD 1.6 Billion in 2021 and is anticipated to reach USD 3.6 Billion in 2031, growing at a rate of 8.4% from 2022 to 2031.
Q2. What is the Infertility Treatment market growth rate?Ans. The growth rate of the Infertility Treatment market is 8.4%.
Q3. Which region holds a major market share for the Infertility Treatment market?Ans. North America holds a major market share of the Infertility Treatment market in 2021.
Q4. Which segment accounted for the largest Infertility Treatment market share?Ans. By end user, fertility center segment accounted for the largest Infertility Treatment market share.
Q5. Who are the key players in the Infertility Treatment market?
Q6. What are the factors driving the Infertility Treatment market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.
Q7. What are the key growth strategies of Infertility Treatment market players?Ans. The key growth strategies of Infertility Treatment market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Infertility Treatment market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Infertility Treatment market during the forecast period.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
The global infertility treatment market was valued at USD 1.6 billion in 2021 and it is anticipated to grow further up to USD 3.6 billion by 2031, at a CAGR of 8.4% during the forecast period.
The inability of a person to reproduce naturally is known as infertility. There are several causes of infertility. The few causes include the aging of the mother, ovulatory problems, tubal obstruction or blockage, sex-transmitted diseases, immunological infertility, genetics, and infertility brought on by male factors. One way to treat infertility is to raise awareness. Other alternatives include IVF (in vitro fertilization), insemination, and drugs that help the body develop during the ovulation phase. The fertility procedure in which the body processes the sperm and eggs out of the body is referred to as assisted reproductive technology (ART). In an ART operation, a woman's ovaries are surgically removed, her eggs are fused with sperm in a lab, and either she returns the eggs to her body or donates them to another woman. With the aid of many diagnostic techniques, including ultrasound, physical examination, and evaluating sperm count & quality, among others, infertility can be identified in both men and women.
Market Trends and Drivers
Due to a variety of circumstances, including the rising trend of late marriages and the rise in age-related infertility, the fertility rate globally is progressively dropping. By 2030, it is predicted that there will be 2.4 offspring for every woman worldwide, and by 2050, there will be 2.2. The need for infertility treatment items that identify the reproductive window in males and females has significantly increased as a result of the dropping fertility rate.
Similarly, players in the infertility treatment market can expect to find considerable growth possibilities in emerging markets like China, India, Brazil, and Mexico. The increased emphasis on healthcare infrastructure upgrades is what distinguishes the market for infertility treatments in Asia and other emerging nations. The medical tourism sector is also flourishing in developing nations for a variety of reasons. Numerous doctors and surgeons throughout Asia have received their training at prestigious institutions in the US and Europe, and healthcare facilities and procedures are of a high standard. Emerging nations like India, China, Singapore, Thailand, Brazil, and Malaysia offer a lot of potential for the expansion of the market for infertility treatments. Players are increasingly focusing on strategic agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions to increase their presence in these markets and tap a large number of customers in order to take advantage of the significant growth opportunities in emerging countries. Additionally, government measures to make infertility treatments more accessible as well as the rise in fertility clinics are causing an increase in infertility treatment procedures in developing nations.
Market Restraints and Challenges
Thousands of rounds of ART procedures including in vitro fertilization (IVF) are carried out year across the globe in addition to reproductive surgery. Due to the absence of reimbursement policies, the cost of IVF therapy varies from nation to nation. The development of this market is being constrained by a lack of insurance coverage and a problematic reimbursement environment in several regions of the world.
Global Infertility Treatment Market Segmental Overview
The report analyses the global infertility treatment market based on the product, procedure, patient type, end user, and region.
Global Infertility Treatment Market by Product
Based on the product, it is segmented into equipment, media & consumables, and accessories. The equipment segment is anticipated to capture the largest share in infertility treatment market. The existence of well-established firms with a robust product lineup and technological developments are to thank for this industry's rapid rise. Along with the players' increasing attention to base development through the use of various tactics, such as the introduction of new equipment, showcases throughout the world are likely to aid in the segment's growth.
Global Infertility Treatment Market by Procedure
Based on the procedure, it is segmented into assisted reproductive technology, artificial insemination, fertility surgeries, and others. The assisted reproductive technology segment is anticipated to dominate the market during the forecast period. The segment's expansion is projected to be aided by the increasing popularity of ART, its rising success rate, and its expanding acceptance on a global scale.
Global Infertility Treatment Market by Patient Type
Based on the patient type, it is segmented into females and males. The female infertility treatment segment is anticipated to dominate the market during the forecast period. The market for treating female infertility is expanding as a result of declining female fertility rates, increased availability of different fertility treatment choices, and an increase in the number of reproductive clinics around the world.
Global Infertility Treatment Market by End User
Based on the end user, it is segmented into fertility centers, hospitals & surgical clinics, cryobanks, and research institutes. The fertility centers segment accounted for the largest share of the infertility treatment market during the forecast period. Some of the factors that are likely to contribute to the segment's rapid growth include the rising government initiatives to establish fertility clinics, initiatives taken by major international healthcare providers to establish fertility centers, and the rising popularity of IVF and ICSI treatment globally.
Geographical Analysis of the Global Infertility Treatment Market
Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The Asia Pacific region is anticipated to dominate the market during the forecast period. Significant increase in medical travel, increasing public knowledge of the availability of infertility treatment options, expansion of fertility clinics in the region, rising healthcare costs, rising infertility rates in the region, and government measures to make infertility treatment more accessible in developing countries.
Major Players in the Global Infertility Treatment Market COVID-19 Impact
Currently, the coronavirus pandemic is posing a number of difficulties for patients and clinical healthcare professionals all around the world. The main hurdles facing healthcare systems around the world are logistical problems, managing patients with the disease, prioritizing patients with comorbidities and pre-existing disorders, and protecting public and hospital frontline employees from contact with the COVID-19 virus. Infertility affects one in six couples of reproductive age, and many of them seek out therapies like intrauterine insemination (IUI) and in vitro fertilization (IVF), which call for in-person consultations to be completed. Only 5 lakhs of the 30 lakh persons who seek infertility treatment in India each year actually have IVF or intrauterine insemination (IUI) procedures done. During the COVID-19 epidemic, there was a 90% decrease in the number of IVF cycles performed. The spread of COVID-19 has had an impact on couples that were considering IVF treatment prior to the pandemic as well as fertility clinics due to the cancellation of IVF procedures.
Recent Developments
- July 2021, Hamilton Thorne Ltd. Received FDA approval for the commercialization of the GYNEMED GM501, a ready-to-use medium designed for in vitro washing and handling procedures of human oocytes and embryos in the US and Europe.
- February 2021, Cooper Surgical announced a partnership with Virtus Health to strengthen its fertility technology, increasing the accessibility of advanced treatment to infertile couples.
- November 2020, Genea Biomedx collaborated with Hamilton Thorne to commercialize Genea Biomedx’s fertility products in the US and Canada.
- March 2019, Vitrolife, market leader of time-lapse systems for use in assisted reproduction, launched Embryoscope+ in the Chinese market which is world’s largest market in terms of IVF treatments.
- March 2018, Genea, leading company in fertility group, opened a fertility clinic in Melbourne has helped the company to expand its services in Australia.
- April 2018, Baker Ruskin made a partnership with I&L Biosystems UK Ltd. As its UK sales partner with the aim to expand its sales and distribution in the UK market
Q1. How big is the Infertility Treatment market?Ans. The global Infertility Treatment market size was USD 1.6 Billion in 2021 and is anticipated to reach USD 3.6 Billion in 2031, growing at a rate of 8.4% from 2022 to 2031.
Q2. What is the Infertility Treatment market growth rate?Ans. The growth rate of the Infertility Treatment market is 8.4%.
Q3. Which region holds a major market share for the Infertility Treatment market?Ans. North America holds a major market share of the Infertility Treatment market in 2021.
Q4. Which segment accounted for the largest Infertility Treatment market share?Ans. By end user, fertility center segment accounted for the largest Infertility Treatment market share.
Q5. Who are the key players in the Infertility Treatment market?
Q6. What are the factors driving the Infertility Treatment market growth?Ans. The major factors driving the growth of the market are the growing healthcare market in emerging countries.
Q7. What are the key growth strategies of Infertility Treatment market players?Ans. The key growth strategies of Infertility Treatment market players are product launch and product approval.
Q8. Which region will provide more business opportunities for the Infertility Treatment market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Infertility Treatment market during the forecast period.
Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.
Table of Contents
156 Pages
- Chapter 1. Market Introduction
- 1.1. Objectives Of the Study
- 1.2. Market Definition and Research & Scope
- 1.3. Research Methodologies
- 1.4. Market Estimation Techniques
- Chapter 2. Executive Summary
- 2.1. Summary
- 2.2. Key Highlights of The Market
- Chapter 3. Infertility Treatment Market Outlook
- 3.1. Infertility Treatment Market Segmentation
- 3.2. Market Dynamics
- 3.2.1. Market Drivers
- 3.2.1.1. Driver 1
- 3.2.1.2. Driver 2
- 3.2.1.3. Driver 3
- 3.2.2. Market Restraints
- 3.2.2.1. Restraint 1
- 3.2.2.2. Restraint 2
- 3.2.3. Market Opportunities
- 3.2.3.1. Opportunity 1
- 3.2.3.2. Opportunity 2
- 3.3. Porter’s Five Forces Analysis
- 3.3.1. Threat Of New Entrants
- 3.3.2. Threat Of Substitutes
- 3.3.3. Bargaining Power of Buyers
- 3.3.4. Bargaining Power of Supplier
- 3.3.5. Competitive Rivalry
- 3.4. Pestle Analysis
- 3.5. Value Chain Analysis
- 3.5.1. Raw Material Suppliers
- 3.5.2. Manufacturers
- 3.5.3. Wholesalers And/or Retailers
- 3.6. Impact Of the Russia and Ukraine War on The Global Infertility Treatment Market
- Chapter 4. The Economic Impact of Covid-19
- 4.1. Overall Impact of Covid-19
- 4.2. Impact Of Covid on The Global Infertility Treatment Market
- 4.3. Economic Impact Analysis
- Chapter 5. Infertility Treatment Market by Product
- 5.1. Market Overview
- 5.2. Equipment
- 5.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.3. Media & Consumables
- 5.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 5.4. Accessories
- 5.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 5.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 6. Infertility Treatment Market by Procedure
- 6.1. Market Overview
- 6.2. Assisted Reproductive Technology
- 6.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.3. Artificial Insemination
- 6.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.4. Fertility Surgeries
- 6.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 6.5. Others
- 6.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 6.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 7. Infertility Treatment Market by Patient Type
- 7.1. Market Overview
- 7.2. Female
- 7.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 7.3. Male
- 7.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 7.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 8. Infertility Treatment Market by End User
- 8.1. Market Overview
- 8.2. Fertility Centers
- 8.2.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.2.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.3. Hospitals & Surgical Clinics
- 8.3.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.3.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.4. Cryobanks
- 8.4.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.4.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- 8.5. Research Institutes
- 8.5.1. Market Size and Forecast, 2021-2031 ($Million)
- 8.5.2. Market Size and Forecast, By Region, 2021-2031 ($Million)
- Chapter 9. Global Infertility Treatment Market, By Region
- 9.1. Overview
- 9.2. North America
- 9.2.1. Key Market Trends and Opportunities
- 9.2.2. North America Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.2.3. North America Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.4. North America Infertility Treatment Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.2.5. The U.S.
- 9.2.5.1. The U.S. Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.2.5.2. The U.S. Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.6. Canada
- 9.2.6.1. Canada Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.2.6.2. Canada Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.2.7. Mexico
- 9.2.7.1. Mexico Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.2.7.2. Mexico Infertility Treatment Market Size and Forecast by End User Product, 2021-2031, ($Million)
- 9.3. Europe
- 9.3.1. Key Market Trends and Opportunities
- 9.3.2. Europe Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.3. Europe Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.4. Europe Infertility Treatment Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.3.5. Germany
- 9.3.5.1. Germany Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.5.2. Germany Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.6. France
- 9.3.6.1. France Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.6.2. France Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.7. U.K.
- 9.3.7.1. U.K. Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.7.2. U.K. Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.8. Spain
- 9.3.8.1. Spain Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.8.2. Spain Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.9. Italy
- 9.3.9.1. Italy Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.9.2. Italy Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.10. Russia
- 9.3.10.1. Russia Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.10.2. Russia Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.3.11. Rest Of Europe
- 9.3.11.1. Rest Of Europe Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.3.11.2. Rest Of Europe Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4. Asia-Pacific
- 9.4.1. Key Market Trends and Opportunities
- 9.4.2. Asia-Pacific Infertility Treatment Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.4.3. Asia-Pacific Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.4.4. Asia-Pacific Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.5. China
- 9.4.5.1. China Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.4.5.2. China Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.6. India
- 9.4.6.1. India Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.4.6.2. India Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.7. Japan
- 9.4.7.1. Japan Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.4.7.2. Japan Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.8. South Korea
- 9.4.8.1. South Korea Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.4.8.2. South Korea Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.4.9. Rest Of APAC
- 9.4.9.1. Rest Of APAC Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.4.9.2. Rest Of APAC Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5. Rest Of the World
- 9.5.1. Key Market Trends and Opportunities
- 9.5.2. Rest Of the World Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.5.3. Rest Of the World Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.4. Rest Of the World Infertility Treatment Market Size and Forecast by Country, 2021-2031, ($Million)
- 9.5.5. Latin America
- 9.5.5.1. Latin America Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.5.5.2. Latin America Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.6. Middle East
- 9.5.6.1. Middle East Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.5.6.2. Middle East Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- 9.5.7. Africa
- 9.5.7.1. Africa Infertility Treatment Market Size and Forecast by Product, 2021-2031, ($Million)
- 9.5.7.2. Africa Infertility Treatment Market Size and Forecast by End User, 2021-2031, ($Million)
- Chapter 10. Competitive Landscape
- 10.1. Market Overview
- 10.2. Market Share Analysis/Key Player Positioning
- 10.3. Developmental Strategy Benchmarking
- 10.3.1. New End User Development
- 10.3.2. Product Launches
- 10.3.3. Business Expansions
- 10.3.4. Partnerships, Joint Ventures, And Collaborations
- 10.3.5. Mergers And Acquisitions
- Chapter 11. Company Profiles
- 11.1. The Cooper Companies Inc.
- 11.1.1. Company Snapshot
- 11.1.2. Financial Performance
- 11.1.3. Product Offerings
- 11.1.4. Key Strategic Initiatives
- 11.1.5. SWOT Analysis
- 11.2. Cook Group
- 11.2.1. Company Snapshot
- 11.2.2. Financial Performance
- 11.2.3. Product Offerings
- 11.2.4. Key Strategic Initiatives
- 11.2.5. SWOT Analysis
- 11.3. Vitrolife
- 11.3.1. Company Snapshot
- 11.3.2. Financial Performance
- 11.3.3. Product Offerings
- 11.3.4. Key Strategic Initiatives
- 11.3.5. SWOT Analysis
- 11.4. Thermo Fisher Scientific, Inc.
- 11.4.1. Company Snapshot
- 11.4.2. Financial Performance
- 11.4.3. Product Offerings
- 11.4.4. Key Strategic Initiatives
- 11.4.5. SWOT Analysis
- 11.5. Esco Micro Pte. Ltd.
- 11.5.1. Company Snapshot
- 11.5.2. Financial Performance
- 11.5.3. Product Offerings
- 11.5.4. Key Strategic Initiatives
- 11.5.5. SWOT Analysis
- 11.6. Genea Biomedx
- 11.6.1. Company Snapshot
- 11.6.2. Financial Performance
- 11.6.3. Product Offerings
- 11.6.4. Key Strategic Initiatives
- 11.6.5. SWOT Analysis
- 11.7. IVFtech ApS
- 11.7.1. Company Snapshot
- 11.7.2. Financial Performance
- 11.7.3. Product Offerings
- 11.7.4. Key Strategic Initiatives
- 11.7.5. SWOT Analysis
- 11.8. FUJIFILM Irvine Scientific
- 11.8.1. Company Snapshot
- 11.8.2. Financial Performance
- 11.8.3. Product Offerings
- 11.8.4. Key Strategic Initiatives
- 11.8.5. SWOT Analysis
- 11.9. The Baker Company, Inc.
- 11.9.1. Company Snapshot
- 11.9.2. Financial Performance
- 11.9.3. Product Offerings
- 11.9.4. Key Strategic Initiatives
- 11.9.5. SWOT Analysis
- 11.10. Kitazato Corporation
- 11.10.1. Company Snapshot
- 11.10.2. Financial Performance
- 11.10.3. Product Offerings
- 11.10.4. Key Strategic Initiatives
- 11.10.5. SWOT Analysis
- 11.11. Rocket Medical plc
- 11.11.1. Company Snapshot
- 11.11.2. Financial Performance
- 11.11.3. Product Offerings
- 11.11.4. Key Strategic Initiatives
- 11.11.5. SWOT Analysis
- 11.12. IHMedical A/S
- 11.12.1. Company Snapshot
- 11.12.2. Financial Performance
- 11.12.3. Product Offerings
- 11.12.4. Key Strategic Initiatives
- 11.12.5. SWOT Analysis
- 11.13. Hamilton Thorne Ltd.
- 11.13.1. Company Snapshot
- 11.13.2. Financial Performance
- 11.13.3. Product Offerings
- 11.13.4. Key Strategic Initiatives
- 11.13.5. SWOT Analysis
- 11.14. ZEISS Group
- 11.14.1. Company Snapshot
- 11.14.2. Financial Performance
- 11.14.3. Product Offerings
- 11.14.4. Key Strategic Initiatives
- 11.14.5. SWOT Analysis
- 11.15. MedGyn Products, Inc.
- 11.15.1. Company Snapshot
- 11.15.2. Financial Performance
- 11.15.3. Product Offerings
- 11.15.4. Key Strategic Initiatives
- 11.15.5. SWOT Analysis
- *The List of Company Is Subject to Change During the Final Compilation of The Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
